
    
      In this study, eligible subject will be enrolled into study arm to accept study treatment.
      Treatment cycles of chemotherapy will be at most 9 cycles which will be decided by
      investigators. The percentage of the patient with tumor cell necrosis rate >90% determined by
      the Independent Review Committee (IRC) will be the primary outcome measures.
    
  